Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Role Overview: In this project, you will leverage your expertise in pulmonary and critical care medicine to help fine-tune large language models (like ChatGPT). Your deep understanding of respiratory diagnostics, ventilator management, and ICU-level decision-making will